Sean Godbout
Vermogen: 263 032 $ op 31-05-2026
Vermogen: 263 032 $ op 31-05-2026
Sean Godbout is currently the Chief Executive Officer at Conforma Therapeutics Corp.
Mr. Godbout is also the Chief Accounting Officer, VP & Global Controller at Biogen, Inc., a position starting in 2025.
Mr. Godbout completed undergraduate studies at Cornell University.
Mr. Godbout completed graduate studies and earned an MBA at Northeastern University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-04-2026 | 1.342 ( 0% ) | 263 032 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| BIOGEN INC. | Comptroller/Controller/Auditor | 01-01-2007 |
Conforma Therapeutics Corp.
Conforma Therapeutics Corp. BiotechnologyHealth Technology Designs and develops drugs for treatment of cancer | Algemeen Directeur | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Conforma Therapeutics Corp.
Conforma Therapeutics Corp. BiotechnologyHealth Technology Designs and develops drugs for treatment of cancer | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau